Healthcare

>

Biotechnology

>

OTC:
IPCIF

INTELLIPHARMACEUTICS INTL

Recent publications about $IPCIF

Intellipharmaceutics Announces Second Quarter 2022 Results

TORONTO, ON / ACCESSWIRE / July 21, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development

Intellipharmaceutics Reports Director Election Results

TORONTO, ON / ACCESSWIRE / February 4, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the

Register by Email

or
Already a member? Sign In